PLGA nanofiber membranes loaded with epigallocatechin-3-O-gallate are beneficial to prevention of postsurgical adhesions

International Journal of Nanomedicine

Volumn 9, Issue 1, 2014, Pages 4067-4078

  Shin, Yong Cheol ^a   Yang, Won Jun ^a   Lee, Jong Ho ^a   Oh, Jin Woo ^a   Kim, Tai Wan ^a   Park, Jong Chul ^b   Hyon, Suong Hyu ^c   Han, Dong Wook ^a  

^a Pusan National University   (South Korea)

^b Yonsei University College of Medicine   (South Korea)

^c KYOTO INSTITUTE OF TECHNOLOGY   (Japan)

Author keywords

Antiadhesion; Epigallocatechin 3 O gallate; Nanofiber membrane; Poly(lactic co glycolic acid); Tissue adhesion barrier

Indexed keywords

EPIGALLOCATECHIN GALLATE; NANOFIBER; OXIDIZED REGENERATED CELLULOSE; POLYGLACTIN; REACTIVE OXYGEN METABOLITE; CATECHIN; LACTIC ACID; POLYGLYCOLIC ACID; PROTECTIVE AGENT;

ADHESION BARRIER; ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; ATOMIC FORCE MICROSCOPY; BIODEGRADATION; BIOMECHANICS; BLOOD COMPATIBILITY; CONTROLLED DRUG RELEASE; CONTROLLED STUDY; DEVICE SAFETY; DEVICE THERAPY; ELECTROSPINNING; MALE; NONHUMAN; PARTIAL THROMBOPLASTIN TIME; PHYSICAL CHEMISTRY; RAT; TENSILE STRENGTH; THERAPY EFFECT; TISSUE ADHESION; WOUND HEALING; YOUNG MODULUS; ANIMAL; ARTIFICIAL MEMBRANE; CHEMISTRY; DRUG EFFECT; PATHOLOGY; PERITONEUM; SPRAGUE DAWLEY RAT;

ANIMALS; CATECHIN; LACTIC ACID; MALE; MEMBRANES, ARTIFICIAL; NANOFIBERS; PARTIAL THROMBOPLASTIN TIME; PERITONEUM; POLYGLYCOLIC ACID; POLYLACTIC ACID-POLYGLYCOLIC ACID COPOLYMER; PROTECTIVE AGENTS; RATS; RATS, SPRAGUE-DAWLEY; TISSUE ADHESIONS;

EID: 84924778846     PISSN: 11769114     EISSN: 11782013     Source Type: Journal    
DOI: 10.2147/IJN.S68197     Document Type: Article

References (52)

1. diZerega GS, Campeau JD. Peritoneal repair and post-surgical adhesion formation. Hum Reprod Update. 2001;7(6):547-555.
2. Alpay Z, Saed GM, Diamond MP. Postoperative adhesions: from formation to prevention. Semin Reprod Med. 2008;26(4):313-321.
3. Kamel RM. Prevention of postoperative peritoneal adhesions. Eur J Obstet Gynecol Reprod Biol. 2010;150(2):111-118.
4. Holmdahl L. The role of fibrinolysis in adhesion formation. Eur J Surg Suppl. 1997;(577):24-31.
5. Liakakos T, Thomakos N, Fine PM, Dervenis C, Young RL. Peritoneal adhesions: etiology, pathophysiology, and clinical significance. Recent advances in prevention and management. Dig Surg. 2001;18(4): 260-273.
6. Hirschelmann A, Tchartchian G, Wallwiener M, Hackethal A, De Wilde RL. A review of the problematic adhesion prophylaxis in gynaecological surgery. Arch Gynecol Obstet. 2012;285(4):1089-1097.
7. Metwally M, Watson A, Lilford R, Vandekerckhove P. Fluid and pharmacological agents for adhesion prevention after gynaecological surgery. Cochrane Database Syst Rev. 2006;(2):CD001298.
8. Ahmad G, Duffy JM, Farquhar C, et al. Barrier agents for adhesion prevention after gynaecological surgery. Cochrane Database Syst Rev. 2008;(2):CD000475.
9. Maciver AH, McCall M, James Shapiro AM. Intra-abdominal adhesions: cellular mechanisms and strategies for prevention. Int J Surg. 2011;9(8):589-594.
10. Ward BC, Panitch A. Abdominal adhesions: current and novel therapies. J Surg Res. 2011;165(1):91-111.
11. Yang B, Gong C, Zhao X, et al. Preventing postoperative abdominal adhesions in a rat model with PEG-PCL-PEG hydrogel. Int J Nanomedicine. 2012;7:547-557.
12. Gao X, Deng X, Wei X, et al. Novel thermosensitive hydrogel for preventing formation of abdominal adhesions. Int J Nanomedicine. 2013;8:2453-2463.
13. Zong X, Li S, Chen E, et al. Prevention of postsurgery-induced abdominal adhesions by electrospun bioabsorbable nanofibrous poly(lactide-co-glycolide)-based membranes. Ann Surg. 2004;240(5):910-915.
14. Lee JH, Go AK, Oh SH, Lee KE, Yuk SH. Tissue anti-adhesion potential of ibuprofen-loaded PLLA-PEG diblock copolymer films. Biomaterials. 2005;26(6):671-678.
15. Hong Y, Fujimoto K, Hashizume R, et al. Generating elastic, biodegradable polyurethane/poly(lactide-co-glycolide) fibrous sheets with controlled antibiotic release via two-stream electrospinning. Biomacromolecules. 2008;9(4):1200-1207.
16. Han DW, Lee JJ, Jung DY, Park JC, Hyon SH. Development of epigallocatechin gallate-eluting polymeric stent and its physicochemical, biomechanical and biological evaluations. Biomed Mater. 2009;4(4): 044104.
17. Hong SC, Lee JH, Lee J, et al. Subtle cytotoxicity and genotoxicity differences in superparamagnetic iron oxide nanoparticles coated with various functional groups. Int J Nanomedicine. 2011;6:3219-3231.
18. Hong SW, Lee JH, Kang SH, et al. Enhanced neural cell adhesion and neurite outgrowth on graphene-based biomimetic substrates. Biomed Res Int. 2014;2014:212149.
19. Jordan CD, Flood JG, Laposata M, Lewandrowski KB. Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Normal reference laboratory values. N Engl J Med. 1992;327(10): 718-724.
20. Leach RE, Burns JW, Dawe EJ, SmithBarbour MD, Diamond MP. Reduction of postsurgical adhesion formation in the rabbit uterine horn model with use of hyaluronate/carboxymethylcellulose gel. Fertil Steril. 1998;69(3):415-418.
21. Knightly JJ, Agostino D, Cliffton EE. The effect of fibrinolysin and heparin on the formation of peritoneal adhesions. Surgery. 1962;52:250-258.
22. Hwang HJ, An MS, Ha TK, et al. All the commercially available adhesion barriers have the same effect on adhesion prophylaxis?; a comparison of barrier agents using a newly developed, severe intra-abdominal adhesion model. Int J Colorectal Dis. 2013;28(8):1117-1125.
23. Jin L, Wang T, Zhu ML, et al. Electrospun fibers and tissue engineering. J Biomed Nanotechnol. 2012;8(1):1-9.
24. Zamani M, Prabhakaran MP, Ramakrishna S. Advances in drug delivery via electrospun and electrosprayed nanomaterials. Int J Nanomedicine. 2013;8:2997-3017.
25. Rajangam T, An SS. Fibrinogen and fibrin based micro and nano scaffolds incorporated with drugs, proteins, cells and genes for therapeutic biomedical applications. Int J Nanomedicine. 2013;8:3641-3662.
26. Vey E, Rodger C, Booth J, Claybourn M, Miller AF, Saiani A. Degradation kinetics of poly(lactic-co-glycolic) acid block copolymer cast films in phosphate buffer solution as revealed by infrared and Raman spectroscopies. Polym Degrad Stab. 2011;96(10):1882-1889.
27. Calheiros R, Machado NFL, Fiuza SM, et al. Antioxidant phenolic esters with potential anticancer activity: a Raman spectroscopy study. J Raman Spectrosc. 2008;39(1):95-107.
28. Fredenberg S, Wahlgren M, Reslow M, Axelsson A. The mechanisms of drug release in poly(lactic-co-glycolic acid)-based drug delivery systems - a review. Int J Pharm. 2011;415(1-2):34-52.
29. Cho HH, Han DW, Matsumura K, Tsutsumi S, Hyon SH. The behavior of vascular smooth muscle cells and platelets onto epigallocatechin gallate-releasing poly(l-lactide-co-epsilon-caprolactone) as stent-coating materials. Biomaterials. 2008;29(7):884-893.
30. Zong X, Ran S, Kim KS, Fang D, Hsiao BS, Chu B. Structure and morphology changes during in vitro degradation of electrospun poly(glycolide-co-lactide) nanofiber membrane. Biomacromolecules. 2003;4(2):416-423.
31. Steiling H, Munz B, Werner S, Brauchle M. Different types of ROS-scavenging enzymes are expressed during cutaneous wound repair. Exp Cell Res. 1999;247(2):484-494.
32. Bryan N, Ahswin H, Smart N, Bayon Y, Wohlert S, Hunt JA. Reactive oxygen species (ROS) - a family of fate deciding molecules pivotal in constructive inflammation and wound healing. Eur Cell Mater. 2012;24: 249-265.
33. Binda MM, Molinas CR, Koninckx PR. Reactive oxygen species and adhesion formation: clinical implications in adhesion prevention. Hum Reprod. 2003;18(12):2503-2507.
34. Awonuga AO, Belotte J, Abuanzeh S, Fletcher NM, Diamond MP, Saed GM. Advances in the pathogenesis of adhesion development: the role of oxidative stress. Reprod Sci. 2014;21(7):823-836.
35. Holmdahl LE, Al-Jabreen M, Risberg B. Role of fibrinolysis in the formation of postoperative adhesions. Wound Repair Regen. 1994;2(3): 171-176.
36. Hatipoǧlu A, Türkyilmaz Z, Mert S. The effects of melatonin on postoperative intraabdominal adhesion formation. Yonsei Med J. 2007; 48(4):659-664.
37. Shimomura M, Hinoi T, Ikeda S, et al. Preservation of peritoneal fibrinolysis owing to decreased transcription of plasminogen activator inhibitor-1 in peritoneal mesothelial cells suppresses postoperative adhesion formation in laparoscopic surgery. Surgery. 2013;153(3):344-356.
38. Hellebrekers BW, Kooistra T. Pathogenesis of postoperative adhesion formation. Br J Surg. 2011;98(11):1503-1516.
39. Kang IK, Kwon OH, Byun KH, Kim YH. Surface modification of polyetherurethaneureas and their antithrombogenicity. J Mater Sci Mater Med. 1996;7(3):135-140.
40. Sun YH, Feng LX, Zheng XX. New-type sulphonated polymer surface for improving blood compatibility. J Appl Polym Sci. 1999;74(12): 2826-2831.
41. Yuan W, Feng Y, Wang H, et al. Hemocompatible surface of electrospun nanofibrous scaffolds by ATRP modification. Mater Sci Eng C Mater Biol Appl. 2013;33(7):3644-3651.
42. Kang WS, Lim IH, Yuk DY, et al. Antithrombotic activities of green tea catechins and (-)-epigallocatechin gallate. Thromb Res. 1999;96(3): 229-237.
43. Abou-Agag LH, Aikens ML, Tabengwa EM, et al. Polyphyenolics increase t-PA and u-PA gene transcription in cultured human endothelial cells. Alcohol Clin Exp Res. 2001;25(2):155-162.
44. Hellebrekers BW, Trimbos-Kemper TC, Trimbos JB, Emeis JJ, Kooistra T. Use of fibrinolytic agents in the prevention of postoperative adhesion formation. Fertil Steril. 2000;74(2):203-212.
45. Aarons CB, Cohen PA, Gower A, et al. Statins (HMG-CoA reductase inhibitors) decrease postoperative adhesions by increasing peritoneal fibrinolytic activity. Ann Surg. 2007;245(2):176-184.
46. Reid RL, Hahn PM, Spence JE, Tulandi T, Yuzpe AA, Wiseman DM. A randomized clinical trial of oxidized regenerated cellulose adhesion barrier (Interceed, TC7) alone or in combination with heparin. Fertil Steril. 1997;67(1):23-29.
47. ten Broek RP, Stommel MW, Strik C, van Laarhoven CJ, Keus F, van Goor H. Benefits and harms of adhesion barriers for abdominal surgery: a systematic review and meta-analysis. Lancet. 2014;383(9911):48-59.
48. Jackson JK, Skinner KC, Burgess L, Sun T, Hunter WL, Burt HM. Paclitaxel-loaded crosslinked hyaluronic acid films for the prevention of postsurgical adhesions. Pharm Res. 2002;19(4):411-417.
49. Maciver AH, McCall MD, Edgar RL, et al. Sirolimus drug-eluting, hydrogel-impregnated polypropylene mesh reduces intra-abdominal adhesion formation in a mouse model. Surgery. 2011;150(5):907-915.
50. Iwamoto T. Clinical application of drug delivery systems in cancer chemotherapy: review of the efficacy and side effects of approved drugs. Biol Pharm Bull. 2013;36(5):715-718.
51. Khalife WI, Kogoj P, Kar B. Sirolimus-induced alveolar hemorrhage. J Heart Lung Transplant. 2007;26(6):652-657.
52. Wu CD, Wei GX. Tea as a functional food for oral health. Nutrition. 2002;18(5):443-444.